Every valuation attached to a humanoid robotics company until now has been a private one, negotiated behind closed doors between founders and venture investors with no public market ever testing whether the number actually holds. That changes this month. Unitree Robotics, formally Yushu Technology Co., priced its initial public offering on Shanghai's STAR Market on Thursday, August 6, 2026, at 150.80 yuan per share, valuing the Hangzhou-based company at roughly 61 billion yuan, or about $9 billion, and setting up what would become mainland China's first publicly traded humanoid robot maker.

Unitree is selling 40.45 million new shares, 10% of its enlarged share capital, aiming to raise about 6.1 billion yuan, or $904 million. Preliminary pricing inquiries wrapped up August 5, subscriptions open August 10, and payment is due by August 12, though Unitree hasn't yet disclosed the date shares will actually begin trading.

A Price Tag for a Sector That's Never Had One

What makes this listing genuinely significant isn't just that it's a first for China's mainland market. It's that humanoid robotics as a category has, until now, only ever been priced in private funding rounds, numbers built on roadmap slides and investor confidence rather than public market scrutiny. Figure, the leading US humanoid robotics company, carries a reported $39 billion private valuation with no public trading history to test it against, a figure investors have largely had to take on faith. Unitree's listing gives the entire sector its first transparent, market-tested price, and the gap between what private markets currently believe humanoid robotics companies are worth and what public investors will actually pay is about to become visible in a way it never has been before.

The Numbers Behind a Rare Profitable Robot Maker

Unlike most companies in this category, Unitree isn't a pre-revenue story built entirely on future promise. The company's 2025 revenue more than quadrupled to 1.7 billion yuan, with humanoid robots specifically generating 867.8 million yuan of that total, a milestone that saw humanoid sales overtake Unitree's quadruped, or four-legged, robots as its largest business line for the first time. Gross margin on core businesses reached 60.13%, a genuinely strong figure for a hardware manufacturer, and one that stands out sharply against a sector still dominated by companies burning cash with no clear path to profitability.

Unitree shipped more than 5,500 humanoid robots in 2025, more than any other manufacturer globally, alongside cumulative sales of over 33,000 quadruped robots, with overseas revenue consistently exceeding 40% of the total. For the first half of 2026, the company projects revenue between 1.052 billion and 1.128 billion yuan, up 35.62% to 45.41% year over year, with net profit attributable to shareholders expected between 258 million and 306 million yuan.

Why DeepSeek's Name Is on This Deal

One detail buried in the prospectus points to how tightly China's AI ecosystem has become interconnected: DeepSeek, the AI lab that shook up global model pricing earlier this year, is listed among the strategic investors participating in Unitree's IPO. That's a meaningful cross-industry signal. A frontier AI model developer putting capital directly into a humanoid robotics manufacturer suggests China's leading AI companies increasingly see physical, embodied robotics as a natural extension of their software capabilities, not a separate bet in an unrelated industry.

Founder Wang Xingxing, who started the company in 2016, will retain 31.29% of shares after the listing, but a considerably larger 65.31% of voting rights, a structure that keeps founder control firmly intact even as outside capital comes in.

A Record-Fast Path Through Chinese Regulators

Unitree's path to this listing moved unusually quickly by the standards of Shanghai's STAR Market. The company filed its IPO application on March 20, 2026, and received regulatory registration approval just 104 days later, a record-breaking timeline for the exchange. Analysts have pointed to that speed as a signal in itself, reflecting how seriously Chinese regulators are treating what they call embodied intelligence, the combination of AI software with physical robotic hardware, as a strategic national priority worth fast-tracking through the approval process. Unitree's public profile had already been building well before the IPO filing, thanks in part to its humanoid robots performing at China's Spring Festival Gala, a nationally televised event that gave the company visibility well beyond the robotics industry itself.

The Export Risk Sitting in the Prospectus Itself

Unitree's own filing doesn't shy away from a real and current risk to its growth story. US sales accounted for only 13.3% of the company's revenue last year, and the prospectus explicitly warns that US tariffs, restrictions on government purchases, export controls, or the loss of existing regulatory approvals could damage overseas growth and disrupt the supply of imported components. That warning reads differently now than it might have a few months ago: the United States added foreign-made humanoid and quadruped robots to the FCC's national-security Covered List just days before this IPO priced, a rule that effectively closes off what would otherwise be one of Unitree's larger addressable export markets right as the company is trying to prove its growth story to public investors for the first time.

What Happens When Unitree Actually Starts Trading

The real test arrives once shares actually begin changing hands. Secondary-market chatter has already anchored expectations well above Unitree's roughly $9 billion IPO valuation, with some estimates running toward $14.8 billion once trading opens, a gap that reflects just how much pent-up investor appetite has built around a rare profitable name in a sector still mostly defined by companies years away from revenue. Whether that gap closes upward, with shares popping toward those higher secondary-market expectations, or Unitree's public debut ends up tempering some of the enthusiasm that's built around humanoid robotics broadly, will offer the clearest real-world signal yet of how public markets actually value this technology, separate from the private funding rounds and demo videos that have shaped the sector's valuations up to now.